INTRODUCTION
Various murine leukemia virus (MuLV) models have been employed to study the role of the immune system in protection (Earl et al., 1986; Gardner et al., 1980 Gardner et al., , 1977 Hoffman et al., 1991; Ruprecht et al., 1990; Saha et at, 1994; Saha and Wong, 1992) and recovery (reviewed in Chesebro etal., 1990; Robertson et al., 1992 ) from retroviral infections. Apparently, enhanced antiviral immunity is only achieved when complex interactions of both major T-cell subsets, CD4+ as well as CD8+ T-Iymphocytes, are allowed to occur (Robertson et at, 1992; Saha and Wong, 1992) . Additional factors such as hurnoral antibodies may be required to maintain recovery from viral infection (Robertson et al., 1992) . However, the effectiveness of an antiviral immune response might be dependent on the site of virus replication. Like lentiviruses, certain neurotropic MuLV strains invade the central nervous sysCurrent address: Institut fur Medizinische Mikrobiofogie and Hygiene der Universitat Heidelberg, Klinikurri Mannheim, 'Fheodor-KutzerUfer, D-68167 Mannheim, Germany. P Current address: Pathologisches Institut, Icsef-Schneider-Str. 2, D-97080 WOrzbuig, Germany.
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'Current address: Zentrallabor der Medizinischen Univertatsklinik, Josef-Schneider-3[r. 2, 0-97080 Wurzburg,.Germany. 5 To whom reprint requests should be addressed. Fax: +49-931-2013934. tern (CNS), an organ which is immunologically privileged (Hickey, 1991; . Since it is not known whether retroviral neurotropism represents a strategy to escape immune surveillance, we have addressed the question of whether an antiviral immune response was capable of clearing retroviral infections from peripheral organs such as spleen and thymus, as well as from the CNS.
MATERIAL AND METHODS
FB29 virus stock, inoculation of animals, and titration of infectivity A molecular clone of MuLV, FB29 (Sitbon et at., 1986) , was generously donated by Dr. 1. Portis (NIH, Hamilton, MT) and used to generate a virus stock consisting of supernatant from confluently infected Fisher rat embryo (FRE) cells as previously described (Portis et al., 1990) . Inbred F344 Fisher rats were initially purchased from the Zentralinstitut fOr Versuchstierzucht (Hannover, Germany) and bred at our institute. Newborn (<48 hr old) and adult (>5 weeks old) rats were inoculated intraperitoneally (ip) with 50 ill of FB29 virus stock, containing 4 x 104 focus forming units (FFU). Immunization through infection was achieved by two ip inoculations of adult rats with 50 p,1 of FB29 virus stock with a time delay of at least 3 weeks in between the two administrations. Virus titers of virus stocks, sera, spleens, thymi, and brain cells were determined by means of an infectious center assay as described (Czub et al., 1991) involving FB29-specific monoclonal antibody 48 (Robertson et al, 1991) . All focal immunoassays were performed on 12-well tissue culture plates and with aminoethylcarbazole (Sigma) as a substrate (Czub et al., 1991) .
Determination of virus-neutralizing antibodies
Serum samples obtained from rats inoculated as neonates or adults were assayed for virus-neutralizing antibodies exactly as described (Czub et al., 1991) . Briefly, after inactivation for 10 min at 56°, six threefold dilutions of each serum sample were incubated with 50 to 100 FFU of FB29 virus for 1 hr at 37° and subsequently seeded as infectious centers. The neutralizing antibody titer was defined as the highest dilution giving a reduction in foci of at least 75%. Serum from uninfected rats was used as negative control.
FB29-specific cytotoxicity of CD8+ T-Iymphocytes (CTL assay) CD8+ T-lymphocytes were purified from spleen and lymph nodes of neonatally infected, immunized, or uninfected rats by negative selection using monoclonal antibodies OX33, W3/25, and 3.2.3 and immunomagnetic techniques according to the recommendations of the distributor (Dianova, Hamburg, Germany). Prior to immunomagnetic separation, single cell suspensions from spleen and lymph nodes were obtained as described below (adoptive transfer of immune cells). After purification, flow cytometric analysis revealed a greater than 96% purity of CD8+ T-lymphocytes. Subsequently, lymphocytes were restimulated in vitro by coincubation with FB29-infected gamma-irradiated (30 Gy) FRE cells (106 CD8+ T-lymphocytes with 105 FRE cells in 3 ml 10% FCS-RPMI without T-cell growth factors per well of a 12-well tissue culture dish) for 5 days. Initial experiments without restimulation in vitro always failed to result in CD8+ T-lymphocyte-mediated cytotoxicity (data not shown). After in vitro restimulation, T-cells were harvested by BSA-gradient (Bayer, Germany) centrifugation and cytotoxicity was measured against infected and noninfected syngeneic and infected allogeneic targets. Target cells were fusion products of primary rat splenocytes (syngeneic Lewis RT1.A' and allogeneic Brown Norway RT1,An, respectively) and mouse myeloma SP2/0-Ag14. To warrant infection of all respective targets, syngeneic LEW 1 B4/FB29 and allogeneic 8N 3B2/FB29 cells were generated by clonal expansion of single cells infected with FB29. Target cells were labeled with "Cr (100 p.Ci 'Cr in a small volume of PBS/106 cells for 1 hr at 370), washed twice, and incubated with effectors in 200 i./.1 of 10% FCS-RPM1 in a 96-well V-bottom plate at 37° for 5 hr. Radioactivity released into 100 Ecl of supernatants was measured in a y-counter (LKB-Wallac, Turku, Finland), and the percentage of specific cytotoxicity (mean of triple wells) was determined by the following formula: (cpm (experimental} -cpm (spontaneous release})/(cpm (total in 2% Triton X-100) cpm (spontaneous release)) x 100. Spontaneous release never exceeded 25% of the maximum release.
Adoptive transfer
Spleens and lymph nodes of adult naive rats, or of those inoculated twice with FB29 as adults and harvested 7-9 days after the second inoculation, were dissociated with forceps and gentle pipetting in 3% FCSHank's medium, pH 7.4, to yield single cell suspensions. For elimination of erythrocytes, cells were incubated in lysis buffer (155 mM NH4CI, 10 mM KHCO3 , 0.1 mM EDTA) for 5 min on ice, washed twice, and counted in a Neubauer chamber. Cells (1-2 X 106) were given ip to recipient neonatally infected or to age-matched uninfected control rats. For transfers of selective T-lymphocyte populations, 8 X 107 CD4+ or 2 X 107 CD8+ Tcells were administered ip after purification from immunized rats by negative selection as described above.
Isolation, immunolabelling, and cytofluorographic analyses of brain-derived leucocytes and of microglia Purification, subsequent immunostaining, and cytofluorometric analysis of microglia and of leucocytes isolated from brains was performed as described before (for detailed procedure see Dorrles et al., 1991; Sedgwick etal., 1991) , with only minor modifications. Briefly, killed animals were perfused with PBS, brain and spinal cord dissociated, and digested with Collagenase II (Serva, Heidelberg, Germany) and DNAsel (Sigma). The digested cell suspension was mixed with 40 ml of 1.05 g/ml Percoll-Hanks (23.5 ml 3% FCSHanks, pH 7.5, + 16.5 ml isotonic Percoll (Pharmacia, Sweden)), underlaid with 5 ml isotonic Percoll, overlaid with 5 ml 3% FCS-Hanks, and centrifuged for 20 min at 1250 g (acceleration time 30 sec, deceleration time 5 min) in a swingout rotor (Hettich, Germany). Cells from the 1.05 g/ml interface were collected, washed, counted, and stained with cell-specific antibodies as described before Schwender etal., 1991; . Antibodies for characterization of microglia were OX1 (which binds to CD45; Sunderland et al., 1979) and 0X42 (which binds to CD11b/c; Robinson et al., 1986) . T-lymphocytes were identified by binding of antibody 1 F4 (specific for the rat CD3 molecule; Tanaka et al., 1989) , OX8 (specific for CD8; Brideau et ai., 1980) , and W3/25 (specific for CD4; Williams etal., 1977) . Only naive (but not activated) and memory T-cells express rat CD45RC, which was stained with OX22 (Spickett et al., 1983) . 8-lymphocytes were identified with antibody OX35, which recognizes a B-cell-specific rat common leucocyte antigen (Woollen et al., 1985) , and with OX1. NK-cells are CD3-negative and -positive for antibody 3.2.3 (Chambers et al., 1989) . Major histocompatibility complex (MHC) class i antigens were stained with antibody OX18 (Fukomoto etal., 1982) and class I I antigens with OX6 . Antibody OX21 specific for the human C3b receptor (Hsiung et al., 1982) was used as a negative control. Cells were analyzed with a fluorescence-activated cell scanner (FACScan, Becton -Dickinson) and Lysis II software package.
Immunohistochemistry
Rats were killed by CO2 inhalation and perfused with 100 ml of PBS. Brains and spinal cords were removed, embedded in OCT compound (Miles Scientific, IN) , and snap frozen at -20°. Immunohistochemical staining of brain sections was performed with monoclonal antibodies directed towards MHC class I (0X18) and II (0X6) molecules, respectively, or control antibody OX21. Sections were incubated with primary antibodies overnight, subsequently with biotinylated multilink Ig (Biogenex, CA) for 30 min at room temperature, and finally with Streptavidin coupled to horseradish peroxidase (Biogenex). Each step was followed by three washes. Development was carried out using 3,3 '-diaminobenzidine (Sigma) as a substrate. Sections were counterstained with hematoxylin.
Histological examination and RNA-RNA in situ hybridization Killed rats were perfused with 100 ml of PBS and subsequently with 100 ml of 3.7% formaldehyde in PBS, pH 7.4. Brains and spinal cords were removed and immersion fixed in 3.7% formaldehyde in PBS, pH 7.4, for 48 hr, embedded in paraffin, and processed essentially as described for in situ hybridization (Mori et al., 1990) or stained with hematoxylin and eosin for histological examination. An antisense RNA probe encompassing an XbalClal pol-env fragment of the FB29 genome (Perryman et al., 1991) was transcribed in vitro using the SP6 promotor of the plasmid Bluell KS+/-(Stratagene) and incorporating [85S]UTP. Sense RNA and irrelevant probes (Sly, Boma), as well as tissues from uninfected age-matched rats, were used as controls. Slides were exposed to photographic emulsion (Ilford K2, UK) at 4° for 3 to 4 weeks before development.
RESULTS
Immune response to MuLV-FB29 after inoculation of neonatal and adult Fisher rats (b, d) . In brains of neonatally inoculated but untransferred rats expression of both MHC class I (b, 16 dpt) and II (d, 13 dpt) was very low or undetectable and indistinguishable from noninfected controls (not shown). In contrast, high levels of MHC class I (a, 13 dpt; aa, 16 dpt) and II (c, cc, 13 dpt) were found in brains of neonatally inoculated and immunotransferred rats. MHC class I and II expression was mainly detected in association with vascular elements, microglia, and mononuclear infiltrates; magnifications, aa, x190; a-d, X270. of various organs, such as blood, spleen, thymus, and CNS (Fig. 1) . Neurological disease occurred after around 8-12 weeks postinfection (pi) and was characterized by very mild reflex abnormalities of the limbs. Virus-induced noninflammatory spongiform encephalopathy was observed regularly, and vacuolar lesions were distributed over brainstem and spinal cord (Fig. 2) . Titers of virusneutralizing antibodies of sera from eight neonatally inoculated Fisher rats obtained at 25 to 76 days postinfection (dpi) were below 1:5, as were titers from uninfected control animals. To address the cellular immunity, CD8+ cells isolated from three individual neonatally inoculated rats were stimulated in vitro on irradiated infected FRE cells for 5 days. None of these attempts was successful in maintaining or expanding a sufficient number of lymphocytes that could be used for the CTL assay. It thus appeared that neonatally inoculated rats did not develop either a substantial humoral or cellular immunity against FB29.
In contrast, infection of adult rats resuited in a virusspecific humoral and cellular immune response. Immunization through infection was achieved by two ip inoculations with FB29 virus. Neutralizing antibody titers from seven animals reached levels of 1:81 to at around 4 weeks pi. In three independent experiments, CD8+ Tlymphocytes isolated from rats twice inoculated as adults, specifically lysed target cells in a MHC class I restricted manner (Fig. 3) . Viremia levels of three rats infected as adults were below 10 FFU/ml serum. Taken together, our results are well in accordance with those of related mouse models of MuLV infection Saha and Wong, 1992) in that neonatal inoculation resulted in specific immune nonresponsiveness, but inoculation of adults yielded a strong humoral and cellular immune response.
Reduction of virus titers in serum, spleen, and thymus after adoptive transfer of immune cells
In order to find out whether immunotherapy of an established retroviral infection could be achieved in vivo, adoptive transfer experiments were carried out. Fourteen to seventeen days pi, rats immunologically tolerant towards FB29 (i.e., neonatally inoculated) received 1-2 X 108 leucocytes (ip) derived from spleens and lymph nodes of immunized rats. At the time of transfer, virus titers had already reached high levels in the serum, spleen, thymus, and CNS of the recipient neonatally inoculated rats (Fig. 1) . In untransferred control animals virus titers did not change thereafter (Fig. 1) . In most transferred rats, viremia titers declined from 103-10° FFU/ml serum to FFU/ml serum beginning from 7 days posttransfer (dpt) (Fig. 1) . The number of virus producing spleen cells was reduced by up to more than 1000-fold when compared to controls at 11-15 days after transfer (Fig. 1) . In thymi of immunotransferred rats, only 0-1000 of 106 cells still produced virus at around 15 dpt while 106 thymus cells from untreated rats contained 104-106 productively infected cells (Fig. 1) . However, the virus titers of serum, spleen, and thymus of immunotransferred rats began to increase again at around 19 dot. During 7-17 dpt, most rats receiving unfractionated cells from immunized rats developed an acute clinical disease characterized by lethargy and a rough coat. Postmortem examination of these animals revealed enlarged lymph nodes and spleens. Thymi were highly atrophic. Fifteen percent of all transferred rats died between 7 and 17 dpt but no further deaths were observed over the 40 days of observation (data not shown). At 21 dpt, transferred animals became indistinguishable from controls again in terms of clinical status and gross morphology of the spleens, lymph nodes, and thymi. Our data demonstrate that the number of retrovirus-infected cells from lymphatic organs could efficiently be reduced by a vigorous immune response in vivo, although the antiviral activities observed in this model were clearly limited by their short duration.
Inflammation but no reduction of viral titers in brains of adoptively transferred rats In contrast to peripheral organs, numbers of virus producing cells in the brain were not affected by immunotransfers and remained at similar levels to those of untransferred animals (Fig. 1) . To explore the paucity of the antiviral immune response in the CNS of adoptively transferred rats, we analyzed the brains of neonatally infected recipients, of untransferred infected, and of transferred noninfected controls at various timepoints post-transfer for an influx of lymphocytes and natural killer cells (NK-cells). Beginning from 8 dpt, increased numbers of leucocytes were observed in brains of neonatally infected immunotransferred rats but not in control animals. Infiltrating CD3+/CD8+ lymphocytes (Fig.  4b) were found more frequently than CD3+/CD4+ (Fig,  4a ) and CD3-/3.2.3+ cells (i.e., NK-cells) (Fig. 4d) . More than 90% of all CD3+ cells were negative for rat CD45RC, indicating that the infiltrating lymphocytes were not naive but of primed or memory phenotype (data not shown). The numbers of B-cells were similar in all brains of transferred and control animals at any given timepoint (Fig. 4c) . After 20 dpt, infiltration of leucocytes into the CNS could no longer be observed (Fig. 4a-d) . Thus it appeared that although activated lymphocytes invaded the infected brains in high numbers, elimination of virus-infected cells in the brain did not take place, in stark contrast to the fate of infected cells in peripheral organs (Fig. 1) .
Upregulation of MHC class 1 and 11 molecules on both, microglia, and other brain cells after influx of leucocytes into brains of adoptively transferred rats An important requirement for the classic 008+ T-cellmediated cytotoxicity is the expression of MHC class I molecules on the target cells. Analyzing the brains of 10 animals, positive signals of RNA-RNA in situ hybridizations using an FB29-specific envelope probe were found to be scattered predominantly over brain stem areas distant from pathological lesions. Positive signals were associated with glial cells but not with neurons nor vascular elements (Fig. 5) . By morphological criteria, (small polymorphic rather hyperchromatic nuclei and scanty cytoplasms), these cells were regarded as microglia. However, cell-specific immunohistochemical staining in combination with in situ hybridization is necessary to verify this diagnosis. As revealed by cytofluorographic analyses, expression of both MHC class I and II molecules on microglial cells isolated from uninfected as well as from neonatally inoculated rats was found to be very low at all timepoints pi (Figs. 4e and 4f) . The latter results are in accordance with data obtained from immunohistochemical studies on mice neonatally inoculated with other variants of MuLV (Korostoff et al., 1991; Nagra et al., 1993) and imply that MuLV infection of brain cells per se was not sufficient to induce upregulation of MHC expression. In contrast, increased levels of MHC class I and II molecules on microglia from infected transferred but not control rats were initially found when leucocytes invaded the CNS, i.e., at 8 dpt (Figs. 4e and 4f ). This observation was confirmed by immunohistochemical analysis, showing elevated levels of MHC molecules associated with glial and vascular elements only in transferred (Figs. 6a and 6c) but neither in untransferred noninfected nor FB29-infected control animals (Figs. 6b and 6d), MHC expression on microglia decreased again with ongoing time and lower numbers of leucocytes in the CNS (Figs. 4e and 4f) . These results suggest that the inflammatory response was associated with the induction of MHC antigens in FB29-infected brains, but that even in the presence of MHC molecules and lymphocytes in the CNS, clearance of virus-infected brain cells could not be achieved.
No apparent effects after transfers of naive cells or of T-Iymphocyte subpopulations
No decrease of viral titers was observed after transfer of cells isolated from adult naive rats (Fig. 7) . Also, viral titers of infected recipients appeared not to change after selective transfers of either 004+ or CD8+ T-lymphocytes isolated from immunized rats (Fig. 7) . None of the rats receiving either naive cells, or immune CD4+ or CD8-* T-lymphocytes developed clinical disease or exhibited gross morphological alterations of the spleen, lymph nodes, or thymus (data not shown). Furthermore, numbers and the profile of subpopulations of leucocytes isolated from the brains of these animals were indistinguishable from control rats (data not shown). Thus, efficient antiviral immunity could not be achieved by transfers of T-lymphocyte subpopulations alone or of cells from naive lymph nodes or spleens.
DISCUSSION
The present study was carried out to investigate the immunotherapeutic potentials of adoptively transferred cells on an established retroviral infection of rats. We first showed that neonatally inoculated rats exhibit neither virus-specific neutralizing antibodies nor cytotoxic CD8+ T-cells. Probably favored by the absence of a specific immune response, productive virus infection of various organs, like the spleen, thymus, blood, and CNS persisted over a long period. In contrast, inoculation of adult animals resulted in a strong humoral and cellular immunity against MuLV FB29 and no apparent infection. After transfer of unfractionated cells from immunized spleens and lymph nodes numbers of virus-infected spleen and thymus cells as well as viremia titers of recipient neonatally inoculated rats could be drastically reduced in vivo. Thus, immunotherapy of a retroviral infection was achieved by transfer of primed immune cells. With respect to studies utilizing MuLV-immunized mice, we assume that the specificity of the effective cellular and/or humoral immunity associated with the transferred cells was mainly targeted against viral envelope proteins (Robertson et al., 1992; Saha et at, 1994) , although gag proteins might have played a role in the development of immunity as well (Holt et al., 1986; Klarnet et at, 1989) . However, immunotherapy in our study was also associated with acute clinical disease of most and death of some rats, as well as with atrophic thymi and enlarged spleens and lymph nodes. These phenomena were probably the result of immunopathogenic mechanisms, like virus-specific cell-mediated cytotoxicity, although further analyses on the ultrastructural level are needed to determine the precise nature and extent of the alterations. It should be noted that expression of neurological signs due to noninflammatory neurodegeneration was earliest observed around 8-12 weeks pi and was thus not involved in this acute disease.
Around 3 weeks post-transfer, we observed rising viral titers, recovery from acute clinical disease, gross morphological reconstitution of lymph nodes and thymi, and no further enhanced influx of leucocytes into the brains of adoptively transferred rats. Altogether this suggested an end of immunopathological alterations due to a decline of antiviral immunity. It is possible that virus-specific lymphocytes were disabled and/or disappeared because they had exhaustively been induced by the large number of virus-infected cells of recipient animals. A similar explanation was proposed for observations made on mice infected with high doses of lymphocytic choriomeningitis virus (LCMV). After an initial vigorous immune response, LCMV-specific T-lymphocytes completely disappeared and virus persisted lifelong. The phenomenon occurred only after high but not low doses of LCMV and was explained to be due to exhaustive induction of LCMVspecific T-lymphocytes (Moskophidis et at, 1993) . It was termed tolerance by exhaustion or high zone tolerance (Moskophidis et at., 1993; vonBoehmer, 1993) and is probably a suitable explanation for the decline of antiviral immunity seen in our model as well.
Protection and recovery from MuLV-mediated diseases has previously been shown to involve dominantly CD8+ CTLs (Robertson et al., 1992; Saha and Wong, 1992) , although CD4+ T-lymphocytes (Robertson et al., 1992; Saha and Wong, 1992) and/or antibodies (Saha et al., 1994) could exert some antiviral immunity, too. In our study, transfers of immune CD4+ or CD8+ T-lymphocytes alone were neither sufficient to reduce viral titers nor to result in immunopathological alterations in recipient rats. Several reasons might have been responsible for this failure. Virus-specific T-lymphocytes might have been too low in number among the transferred subpopulations. This argument is strengthened by the fact that cytolytic activity of CD8+ T-lymphocytes could never be detected directly ex vivo but only after restimulation and expansion in vitro. However, preliminary results from transfers with CD8+ lymphocytes restimulated on FB29-infected FRE cells in vitro were identical to those without stimulation and did not change viral titers in recipient rats. Furthermore, homing of virus-specific T-lymphocytes into virus-infected target organs might have been impaired if transferred alone. Additionally, the pool of virus-specific T-lymphocytes might have been drained out rapidly by a mechanism as described above (Moskophidis et al., 1993; vonBoehmer, 1993) and was neither sufficiently replenished nor expanded by new priming and/or proliferation. In any case, our data suggest that immunotherapy required the concerted action of various cell populations. Interestingly, only cells from immune animals (donors) but not from neonatally inoculated rats (recipients) were able to complement the transferred lymphocyte subpopulations sufficiently to install therapeutic antiviral immunity. For the inauguration of (partially) protective immunity, however, the transfer of subpopulations of immune T-lymphocytes alone appears to be sufficient (Saha and Wong, 1992) .
To further explore the requirements for initiating immunotherapeutic immunity, neonatally inoculated rats were transferred with unfractionated cells from nonimmunized animals. In contrast to transfers with primed cells, no substantial antiviral immunity occurred. Similarly, Moloney-ts1 MuLV-mediated disease could only be prevented by transfers of primed lymphocytes but not of naive cells (Saha and Wong, 1992) . The lack of initiation of an immune response cannot be explained by negative selection of T-cells in the course of thymic maturation -as it is proposed to be the case in neonatally inoculated animals -because the vast majority of transferred unprimed cells were no longer subjected to thymic maturation. Instead it is possible that cells involved in priming and proliferation of T-cells might have been functionally altered by infection with FB29, especially since infection with Friend MuLV is frequently associated with various forms of immunosuppression (Dai et al., 1994) . However, a more complete study is necessary to establish any final conclusions. On the other hand, lack of initiation of an antiviral immune response after adoptive transfer of naive cells may not (solely) be due to immunosuppressive effects of FB29. Apparently, cells from tolerant animals might disable adoptively transferred naive lymphocytes in that they also become tolerant. This process of "infectious tolerance" has been demonstrated to maintain long-term transplantation tolerance (Qin et al., 1993) . Although it is unclear at this time which mechanism(s) prevented the initiation of antiviral immunity, it is likely to be an active process provided by the recipients of transfers and might also interfere with initiation, maintenance, and/or renewal of therapeutic immunity.
Transfers of unfractionated primed cells did not reduce the levels of CNS infection. This result contrasted the situation in peripheral organs. The failure to reduce viral CNS titers seemed not to be due to an absence of inflammatory cells as revealed by flow-cytometric analyses. Brains of adoptively transferred rats were transiently invaded by CD45RC negative, i.e., primed CD3+/CD8+, CD3+/CD4+, and by CD3-/3.2.3+ lymphocytes. In this instance, the nature of the inflammatory process observed in our model resembled CNS inflammations of other viral infections (e.g., Dorries et al., 1991; Hudson and Streilein, 1994; Stitz et al., 1992) . According to current hypotheses, CNS inflammation is initiated after activated lymphocytes enter the brain and some (virus-)specific Tlymphocytes encounter their specific antigen in the context of the appropriate MHC molecule on the surface of an antigen presenting cell, resulting in a cascade of signaling to attract further leucocytes (Hickey, 1991; Emrich et al., 1994) . This view is supported by our findings in that enhanced numbers of lymphocytes were only seen in immunotransferred neonatally inoculated but not in immunotransferred noninfected nor other control rat brains. We also showed that the influx of lymphocytes was tightly associated with the upregulation of MHC molecules on microglia and on other brain cells. This suggested that the secretion of cytokine(s), probably interferon-'y (Sethna and Lampson, 1991) , was occurring. It thus appeared that at least some virus-specific T-lymphocytes interacted with FB29-infected brain cells, however, without reducing the level of CNS infection. We are currently investigating whether this failure might be due to possible immunomodulating effect(s) of FB29 such as upregulated expression of immunosuppressive cytokines like transforming growth factor 0 or other cytokines. We are also looking into the levels of neutralizing antibodies in the CNS which might be of importance to fight the retroviral CNS infection, similar to that which has been suggested for a variety of other viral infections (Dorries eta) ., 1991; Levine et al., 1991; Saha et al., 1994) . Independent from the outcome of these future studies, however, our data suggest that immunotherapy of a retroviral CNS infection requires mechanisms different from the immunotherapeutic processes in peripheral organs which are believed to be mediated at least partly by MHC class I restricted CD8+ T-Iymphocyte cytolysis. Interestingly, this statement might be of more general importance, because histopathological observations on those relatively rare cases of viral clearance from the CNS unanimously state that the degree of brain tissue destruction is unexpectedly low (Levine et al., 1991; Oldstone et al., 1986; Pearce et al., 1994; Sussman et al., 1989) . Consequently, it has been suggested that soluble factors might be involved in the clearance of viral infec-tions from the CNS and that the profile of cytokines (0#d-stone et at., 1986; Pearce et al., 1994; Sussman et al., 1989; Tishon et al., 1993) and/or antibodies (Levine et al., 1991) in the CNS appears to be important for viral clearance from the CNS and should further be investigated in order to decipher the discrepancy of CNS versus peripheral immunology. In light of these studies, and with respect to our data and the life cycle of retroviruses, it seems unlikely that immunotherapeutical approaches might be sufficient to eradicate retroviral reservoirs from the CNS,
